Long-term(?) Antibiotic Treatment with Roxithromycin in Patients with Multiple Sclerosis
R. Woesner et al, Dept. of Neurology, Westpfalz Medical Center, 67655 Kaiserslautern, Germany
They found no difference in the EDSS of relapsing remitting people after treatment of a year, compared to people on a placebo, however, the long term treatment consisted of three periods of six weeks over the course of a year, and only one antibiotic was involved. Is this surprising? What ...